Equities

Epsilon Healthcare Ltd

Epsilon Healthcare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.024
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-7.69%
  • Beta1.2368
Data delayed at least 20 minutes, as of Dec 18 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of AUD
(except for per share items)
Fiscal data as of Dec 31 2022202220212020
ASSETS
Cash And Short Term Investments0.862.346.97
Total Receivables, Net3.152.351.42
Total Inventory02.422.04
Prepaid expenses0.760.710.58
Other current assets, total------
Total current assets4.767.8111
Property, plant & equipment, net161820
Goodwill, net04.475.44
Intangibles, net00.500.48
Long term investments------
Note receivable - long term0.120.130.26
Other long term assets------
Total assets203137
LIABILITIES
Accounts payable4.332.382.16
Accrued expenses0.950.820.40
Notes payable/short-term debt2.553.663.79
Current portion long-term debt/capital leases00.120.34
Other current liabilities, total0.100.160.39
Total current liabilities7.937.147.08
Total long term debt0.650.660.97
Total debt3.204.445.11
Deferred income tax2.653.193.89
Minority interest------
Other liabilities, total------
Total liabilities111112
SHAREHOLDERS EQUITY
Common stock474542
Additional paid-in capital------
Retained earnings (accumulated deficit)(50)(25)(16)
Treasury stock - common------
Unrealized gain (loss)8.71----
Other equity, total3.27--0
Total equity9.272025
Total liabilities & shareholders' equity203137
Total common shares outstanding300223189
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.